Groesbeck Investment Management Corp NJ cut its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 21.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,363 shares of the company’s stock after selling 2,600 shares during the quarter. AbbVie makes up about 2.0% […] Read this story